How long should GuBang Alendronate Sodium Tablets be taken for the treatment of osteoporosis?

Alendronate Sodium Tablets are bone metabolism regulators. The active ingredient, alendronate sodium, exhibits strong affinity for hydroxyapatite in bone tissue, enabling it to incorporate into the hydroxyapatite crystal matrix of bone. This action effectively inhibits osteoclast activity and, leveraging the potent anti-bone-resorption properties of osteoclasts, suppresses bone resorption—thereby increasing quantitative ultrasound (QUS) bone mineral density (BMD). Alendronate Sodium Tablets demonstrate excellent therapeutic efficacy for osteoporosis in postmenopausal women as well as in men with osteoporosis arising from various etiologies. However, treating osteoporosis is a complex and prolonged process. Moreover, the severity of osteoporosis varies significantly among individuals, and the extent of BMD recovery following treatment also differs markedly from patient to patient. Therefore, although GuBang Alendronate Sodium Tablets are highly effective for osteoporosis management, the optimal duration of treatment must be determined individually based on each patient’s clinical response—no universal recommendation can be made. Recommendations: 1. GuBang Alendronate Sodium Tablets are manufactured by Hebei Group Ouyi Pharmaceutical Co., Ltd. The drug’s approval number is National Medical Products Administration (NMPA) Approval No. H10980109. Patients should verify this information before purchase. 2. Patients with osteoporosis should regularly consume calcium-rich foods, such as pork or beef marrow bones, cartilage, dried shrimp, laver (nori), hair seaweed (fat choy), black fungus, tangerines, and walnuts.